Patents by Inventor Mark M. Kowalski

Mark M. Kowalski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170128400
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: January 12, 2017
    Publication date: May 11, 2017
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Patent number: 9561200
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: February 7, 2017
    Assignee: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20140107210
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20140073643
    Abstract: Described herein is a method for treating a subject experiencing anemia, comprising administering to the subject an amount of N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-benzamide [CYT387 ] or a related compound effective to maintain or elevate the hemoglobin level. The anemic subjects including those afflicted with a myeloproliferative disorder, such as primary myelofibrosis.
    Type: Application
    Filed: November 29, 2011
    Publication date: March 13, 2014
    Applicant: YM BIOSCIENCES AUSTRALIA PTY LTD
    Inventors: Gregg D. Smith, Rose Fida, Mark M. Kowalski
  • Patent number: 8623920
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: January 7, 2014
    Assignee: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Patent number: 8110606
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: February 7, 2012
    Assignee: Aaipharma Services Corp.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20110300207
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: August 8, 2011
    Publication date: December 8, 2011
    Applicant: aaiPharma Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Patent number: 7939518
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: May 10, 2011
    Assignee: Aaipharma Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Patent number: 7884095
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: February 8, 2011
    Assignee: aaiPharma Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20100222430
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: May 3, 2010
    Publication date: September 2, 2010
    Applicant: AAIPHARMA INC.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20100144882
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: February 16, 2010
    Publication date: June 10, 2010
    Applicant: AAIPHARMA INC.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Patent number: 7662858
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: February 24, 2009
    Date of Patent: February 16, 2010
    Assignee: aaiPharma, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20090292022
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: February 24, 2009
    Publication date: November 26, 2009
    Applicant: aaiPharma Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Publication number: 20090292023
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: May 15, 2009
    Publication date: November 26, 2009
    Applicant: AAIPHARMA INC.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore